This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Reducing Injuries From Medication-Related Falls Using Computerized Alerts for High Risk Patients

This study is currently recruiting participants.
See Contacts and Locations
Verified March 2017 by Robyn Tamblyn, McGill University
Canadian Patient Safety Institute
Information provided by (Responsible Party):
Robyn Tamblyn, McGill University Identifier:
First received: January 5, 2009
Last updated: March 21, 2017
Last verified: March 2017

Drug-related illness accounts for 5% to 23% of hospital admissions, and is now claimed to be the sixth leading cause of mortality. Older adults are at higher risk of adverse drug-related events, and medication-related fall injuries are the most common adverse event that could be potentially prevented. There are 1.2 million falls per year among Canadian elderly, at a cost of $2.4 billion in health care services, and substantial risk of loss of independence.

The overall purpose of this research program is to reduce medication-related fall injuries by using computerized electronic prescribing and drug management systems to identify high risk patients and provide physicians with patient-specific recommendations for modifying psychotropic medication use to reduce this risk.

Condition Intervention
Fall Related Injury Risk Device: CDS for psychotropic drug management

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Reducing Injuries From Medication-Related Falls by Generating Targeted Computerized Alerts for High Risk Patients Within an Electronic Prescribing System

Resource links provided by NLM:

Further study details as provided by Robyn Tamblyn, McGill University:

Primary Outcome Measures:
  • rate of potentially inappropriate psychotropic medication [ Time Frame: September 2008-July 2010 ]

Secondary Outcome Measures:
  • Fall-related injury risk, fall related injuries, and hospitalizations. [ Time Frame: September 2008 - December 2011 ]

Estimated Enrollment: 4800
Study Start Date: September 2008
Estimated Study Completion Date: July 2019
Estimated Primary Completion Date: July 2019 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
Physicians in this arm will be using the standard electronic prescription interface.
Experimental: 2
In addition to the standard electronic prescription module, physicians in this arm will receive targeted drugs alert and decision support for psychotropic drug management
Device: CDS for psychotropic drug management
Computerized decision support (CDS) for patients with available supplies of psychotropic medications. The decision support will consist of a screen displaying to the physician the patient's current risk of falling as well as what their risk could be lowered to with modifications to medications.

  Show Detailed Description


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Physicians are eligible for inclusion if they are general practitioners or family physicians in full-time (≥ 4 days/week), fee-for-service practice in Quebec-patients where the study physician has written or dispensed psychotropic medications

Exclusion Criteria:

  • under 65 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00818285

Contact: Robyn Tamblyn, PhD 514-934-1934 ext 32999

Canada, Quebec
McGill University Recruiting
Montreal, Quebec, Canada
Contact: Robyn Tamblyn, PhD    514-934-1934 ext 32999   
Sponsors and Collaborators
McGill University
Canadian Patient Safety Institute
Principal Investigator: Robyn M Tamblyn, PhD McGill University
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Robyn Tamblyn, Professor, McGill University Identifier: NCT00818285     History of Changes
Other Study ID Numbers: RFA06-1035-QC
Study First Received: January 5, 2009
Last Updated: March 21, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Wounds and Injuries
Psychotropic Drugs processed this record on September 20, 2017